ARTICLE | Company News
Beactica, J&J deal
May 2, 2011 7:00 AM UTC
Beactica will use its Sprint surface plasmon resonance (SPR) drug discovery technology to generate small molecule compounds against undisclosed targets for Johnson & Johnson's Janssen Pharmaceutica N....